Align Technology, Inc. (NASDAQ:ALGN) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Align Technology, Inc. (NASDAQ:ALGN) have been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $215.00.

Several equities analysts have commented on ALGN shares. Stifel Nicolaus cut their price target on Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a report on Thursday, July 31st. Evercore ISI upped their target price on Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a research note on Wednesday, July 9th. Mizuho set a $210.00 price target on shares of Align Technology in a research note on Thursday, July 31st. Zacks Research raised shares of Align Technology from a “strong sell” rating to a “hold” rating in a report on Tuesday. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $154.00 price objective (down from $249.00) on shares of Align Technology in a report on Thursday, July 31st.

Align Technology Price Performance

Shares of Align Technology stock opened at $128.70 on Friday. The company has a market cap of $9.33 billion, a PE ratio of 21.70, a price-to-earnings-growth ratio of 1.44 and a beta of 1.70. The firm has a fifty day moving average price of $141.67 and a two-hundred day moving average price of $165.94. Align Technology has a fifty-two week low of $122.00 and a fifty-two week high of $246.19.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the company posted $2.41 EPS. The firm’s quarterly revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. Analysts expect that Align Technology will post 7.98 earnings per share for the current fiscal year.

Align Technology declared that its board has initiated a stock buyback program on Tuesday, August 5th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to buy up to 2% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling

In related news, CEO Joseph M. Hogan acquired 7,576 shares of the firm’s stock in a transaction on Friday, August 1st. The shares were bought at an average cost of $131.49 per share, with a total value of $996,168.24. Following the completion of the acquisition, the chief executive officer owned 184,945 shares of the company’s stock, valued at $24,318,418.05. This trade represents a 4.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.66% of the stock is currently owned by corporate insiders.

Institutional Trading of Align Technology

Several institutional investors have recently bought and sold shares of the stock. Teacher Retirement System of Texas bought a new stake in Align Technology in the first quarter valued at $1,647,000. Asset Management One Co. Ltd. grew its holdings in shares of Align Technology by 14.5% in the 1st quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider’s stock worth $5,024,000 after purchasing an additional 4,009 shares during the last quarter. Czech National Bank grew its holdings in shares of Align Technology by 3.3% in the 2nd quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider’s stock worth $3,153,000 after purchasing an additional 537 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Align Technology during the 1st quarter worth about $20,194,000. Finally, Parallel Advisors LLC lifted its holdings in Align Technology by 66.0% during the 2nd quarter. Parallel Advisors LLC now owns 1,044 shares of the medical equipment provider’s stock valued at $198,000 after purchasing an additional 415 shares during the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.